Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems

Parkinson’s disease (PD) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (CNS). To date, there is no cure for the disease, with current pharmacological treatments aimed at controlling the symptoms. Therefore, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Paccione, Nicola, Rahmani, Mahdieh, Barcia, Emilia, Negro, Sofía
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866990/
https://www.ncbi.nlm.nih.gov/pubmed/36678642
http://dx.doi.org/10.3390/pharmaceutics15010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866990/
https://www.ncbi.nlm.nih.gov/pubmed/36678642
http://dx.doi.org/10.3390/pharmaceutics15010013

Ejemplares similares